Cargando…
Available ablation energies to treat cT1 renal cell cancer: emerging technologies
PURPOSE: An increasing interest in percutaneous ablation of renal tumors has been caused by the increasing incidence of SRMs, the trend toward minimally invasive nephron-sparing treatments and the rapid development of local ablative technologies. In the era of shared decision making, patient prefere...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424924/ https://www.ncbi.nlm.nih.gov/pubmed/30448873 http://dx.doi.org/10.1007/s00345-018-2546-6 |